Katerina Bakunina
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial.
Journal: Blood advances
Published: July 30, 2021
Extent of radiological response does not reflect survival in primary central nervous system lymphoma.
Journal: Neuro-oncology advances
Published: February 22, 2021
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.
Journal: Neuro-oncology
Published: February 09, 2021
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
Journal: Journal of neuro-oncology
Published: October 26, 2020
Contribution of nurses to protective environment in haematopoietic cell transplant setting: an international survey by the European Society for Blood and Marrow Transplantation.
Journal: Bone marrow transplantation
Published: July 02, 2020
Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 25, 2020
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer.
Journal: Radiation oncology (London, England)
Published: January 31, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Journal: Haematologica
Published: December 19, 2019
Last Updated: 09/26/2026